Ardian company logo

The profile is currenly unclaimed by the seller. All information is provided by CB Insights.

Founded Year



Acquired | Acquired

Total Raised




About Ardian

Ardian is a developer of a catheter-based medical device to treat hypertension based in Mountain View, California. Ardian was founded by The Foundry, a medical device incubator based in Menlo Park, California. Ardians investors include Morgenthaler Ventures, Advanced Technology Ventures, Split Rock Partners, Medtronic and Emergent Medical Partners.

Ardian Headquarter Location

1380 Shorebird Way

Mountain View, California, 94043,

United States


Predict your next investment

The CB Insights tech market intelligence platform analyzes millions of data points on venture capital, startups, patents , partnerships and news mentions to help you see tomorrow's opportunities, today.

Ardian Patents

Ardian has filed 21 patents.

patents chart

Application Date

Grant Date


Related Topics




Neurotechnology, Neurophysiology, Implants (medicine), Kidney diseases, Neuroscience


Application Date


Grant Date



Related Topics

Neurotechnology, Neurophysiology, Implants (medicine), Kidney diseases, Neuroscience



Latest Ardian News

Ardian invests in Odealim alongside TA Associates

Jun 2, 2022

01 June 2022 France, Paris Ardian, a world-leading private investment house, announces today it has signed an agreement with TA Associates (“TA”), a global growth private equity firm, to become a co-controlling shareholder of Odealim, a leader in real estate insurance and credit brokerage in France. The Group, managed by Xavier Saubestre (Chairman and CEO) and Xavier Paturel (CEO), has revenues of over €160m. TA, Odealim’s majority shareholder since 2018, will reinvest in the transaction alongside Raise Investissement, an existing minority shareholder, and the management team. The investment, made by the Buyout team at Ardian, will enable the company to move into the next phase of its development and consolidate its position as an integrated leader in the real estate sector through the continuation of its organic growth, diversification and geographic expansion, notably through strategic acquisitions. Founded in 1998, the company became the leading insurance brokerage specialist for real estate professionals (primarily property managers, institutional investors, co-ownerships, etc.) by developing insurance solutions for their properties (including multi-risk building insurance, structural damage policies and unpaid rent guaranties). Backed by TA, the Group has grown revenues from €30m in 2018 to €160m today and increased its geographic coverage across France, through multiple acquisitions, including Ripert de Grissac and Pisano in Marseille, Brun, Assurgérance and BVD in Lyon, Fidentialp in Grenoble and Bâti-assure in Tours. More recently, Odealim has also diversified into mortgage brokerage and mortgage insurance by investing in Digital Insure (2020), an insurtech focused on mortgage insurance, and via the acquisition of real estate mortgage broker Artémis Courtage (2021). Through those two acquisitions, the Group further strengthened its position across the real estate vertical and developed the opportunity for cross-selling synergies between its activities. Thanks to this new investment, the company will be positioned to continue its strong organic growth, further integrate the recently acquired companies, and capitalize on its extensive M&A pipeline. Ardian and TA, both with proven track-records in financial services, will support the Group in further consolidating its positions in existing markets, notably in construction (policies covering structural damage, decennial liability etc. ), as well as in new sectors of activities like the institutional real estate market. “We have followed Odealim closely for several years and have been impressed by the development project led by Xavier Saubestre and Xavier Paturel. We are convinced of the company’s future growth prospects as the French leader in insurance and financing brokerage for real estate professionals. Odealim has demonstrated an impressive organic growth during this period and strong resilience throughout the COVID-19 pandemic, as well as in the current inflationary market context.” Yann Bak, Managing Director in the Ardian Buyout team “Odealim is a key player in insurance and real estate financing brokerage in France. The Group benefits from a recurring business model, significant organic growth prospects, and is a natural consolidator in its different sectors of activity. We are extremely pleased to continue being part of the Odealim story alongside the management team and Raise, and to welcome Ardian, an experienced investor in insurance brokerage." Patrick Sader & Jeremy Drean, Managing Director & Principal, TA Associates “The investment from Ardian, alongside TA, will enable us to continue delivering on our ambitious expansion plans. I am proud of how far we have come with TA whom I would like to thank for their renewed trust. Our teams are working to offer to our clients and partners a high level of expertise and proximity. I would also like to thank Odealim’s executive committee members, who have been involved in this project for several years and have made it a successful, innovative and dynamic company.” Xavier Saubestre, Chairman and CEO, Odealim Parties to the transaction

  • When was Ardian founded?

    Ardian was founded in 2003.

  • Where is Ardian's headquarters?

    Ardian's headquarters is located at 1380 Shorebird Way, Mountain View.

  • What is Ardian's latest funding round?

    Ardian's latest funding round is Acquired.

  • How much did Ardian raise?

    Ardian raised a total of $73.96M.

  • Who are the investors of Ardian?

    Investors of Ardian include Medtronic, Advanced Technology Ventures, Morgenthaler Ventures, St. Paul Venture Capital, Split Rock Partners and 6 more.

  • Who are Ardian's competitors?

    Competitors of Ardian include Endologix, OrthAlign, USGI Medical, Dune Medical Devices, Avantis Medical Systems and 13 more.

You May Also Like


ActiVein develops a patented, dual-action intravenous (IV) catheter that aims to replace the standard conventional "hospital IV line" by enabling both fluid infusion and blood withdrawal using a single vein over an entire hospitalization period, whereas the currently used device aims to allow, regularly, fluid infusion only.

Otothera Corporation

Otothera Corporation is a medical device company developing products to diagnose and treat the more than seven million severe tinnitus (constant ringing in the ears) sufferers in the US. The company was originally named AudioFusion. The company was a 2006 PTEN Growth Accelerator (GAP) winner.


Satiety, Inc. is a medical device company focused on the development of less invasive devices for the treatment of obesity. Obesity is a global health problem, affecting 70 million people in the U.S. and 300 million worldwide, and growth of which is causing increases in obesity-related diseases such as diabetes, high blood pressure and cardiovascular disease. Obesity surgery has been shown to be the only long-term effective means of weight loss for morbidly obese patients. Satiety's first product, the TOGA System, enables physicians to perform a procedure similar to traditional restrictive obesity surgeries, but without surgical incisions. In this procedure, the TOGA System devices are inserted transorally (through the mouth) and are used to reduce the capacity of the stomach to give patients a feeling of fullness after a small meal. The procedure is intended to be safer and easier for patients to tolerate than conventional obesity surgery. Safety and effectiveness of the TOGA System are currently being evaluated in a multi-center U.S. Study and the system is not available for sale in the United States.


synecor is a medical device developer


Otokinetics has been formed to create and promulgate an entirely new product category in hearing aid devices.

Precision Light

Precision Light is a stealth-mode medical device company

Discover the right solution for your team

The CB Insights tech market intelligence platform analyzes millions of data points on vendors, products, partnerships, and patents to help your team find their next technology solution.

Request a demo

CBI websites generally use certain cookies to enable better interactions with our sites and services. Use of these cookies, which may be stored on your device, permits us to improve and customize your experience. You can read more about your cookie choices at our privacy policy here. By continuing to use this site you are consenting to these choices.